Recent regulatory changes require that employers update their HIPAA Privacy Notices no later than February 16, 2026.
Unless an exception applies, the HIPAA Privacy Rule requires covered entities to maintain and provide a Privacy Notice that meets specific content and distribution requirements. Specifically, the notice must outline how the covered entity may use/disclose protected health information (PHI) and explain how the covered entity must safeguard an individual’s PHI.
The responsibility for distributing Privacy Notices depends on the type of funding of the health plan:
Self-Funded Plans:
Plan sponsors hold the primary responsibility for maintaining and distributing the Privacy Notice to plan participants.
Fully Insured Plans:
Plan sponsors can typically rely on their insurance carriers to fulfill the notice distribution obligation, as carriers are usually responsible for providing the Privacy Notice to plan participants. However, employers who create or receive PHI beyond summary health information or information related to enrollment and disenrollment would be responsible for distributing their own Privacy Notice in addition to the carrier.
What Changed?
The Department of Health and Human Services (HHS) issued a ruling known as the 2024 Final Rule. This rule modified how entities can use and disclose Substance Use Disorder information. This ruling aligns the Privacy Notice requirements with the 42 C.F.R. Part 2, which is why it is sometimes referred to as the “Part 2.” Under the new guidance, Substance Use Disorder treatment records carry stricter confidentiality and consent-driven protections by comparison to standard PHI. The new requirements also limit how Substance Use Disorder information may be used, disclosed, or relied upon in civil, criminal, administrative, or legislative proceedings, unless there is specific authorization from the individual or a court order. This heightened standard has triggered the need for an update to existing Privacy Notices.
Updated Privacy Notices must clearly explain the enhanced confidentiality protections that apply to Substance Use Disorder treatment records, including the fact that these records generally cannot be used or disclosed for civil, criminal, administrative, or legislative proceedings without the individual’s specific authorization or a court order.
Acceptable distribution methods follow standard ERISA guidelines. These include distribution by:
Vita includes the Privacy Notice as an addendum to the Summary Plan Description (SPD). The Privacy Notice is also available on a standalone basis. Required action depends on the plan type.
Self-Funded and Level-Funded Plans:Fully-Insured Plans:
If you have any questions, please contact your Vita Account Manager.